United Therapeutics Corp (NASDAQ:UTHR)

101.09
Delayed Data
As of 3:59pm ET
 -0.33 / -0.33%
Today’s Change
75.58
Today|||52-Week Range
127.79
+14.77%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 141.50, with a high estimate of 247.00 and a low estimate of 95.00. The median estimate represents a +39.97% increase from the last price of 101.09.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$2.79
Sales
$357.6M
Reporting Date
Oct 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 15.77%
 
 
 
 
 
 
Growthannually 569.04%
 
 
 
 
 
 

Sales

Growthquarterly -1.23%
 
 
 
 
 
 
Growthannually -1.49%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.